FBTCX is a mutual fund offered by Fidelity Advisor that focuses on investing in biotechnology companies. It is classified as a Class C fund, meaning it has a lower initial investment requirement and may have higher fees compared to other classes. This fund aims to provide investors with exposure to the rapidly growing biotechnology industry, which includes companies involved in the development and commercialization of innovative medical treatments and technologies. With a diverse portfolio of biotech stocks, FBTCX offers potential for long-term growth and may be suitable for investors seeking higher risk and potential returns.
For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.